By Matthias Blamont PARIS (Reuters) – An initial inquiry into a clinical drug trial that left one person dead and five others hospitalized in France last month found that the laboratory conducting the tests was slow to react when the first patient fell ill. A full investigation aimed at identifying the exact causes is expected by end-March, French Health Minister Marisol Touraine said on Thursday. No regulations were breached and it was impossible at this stage to establish exactly what went wrong, Touraine said.
Read more from the original source:
Lab criticized as slow to act in fatal French drug trial
